BSE filing, NSE: AMBER. Summary written from the filing by ALFA Finder's alert engine.
Amber Enterprises India Ltd: key numbers
- Share price
- ₹6,205.00
- Market cap
- ₹21,884 Cr
- Revenue (annual)
- ₹12,186 Cr
- Net profit (annual)
- ₹177.7 Cr
- P/E (TTM)
- 284.7×Sector 41.7×
- Promoter holding
- 38.09%+0.00% QoQ
- FII holding
- 20.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amber Enterprises India Ltd
All →Amber Enterprises India Acquisition Worth ₹176 Cr
Amber Enterprises' subsidiary IL JIN will acquire the remaining 40% stake in Power-One for ₹176 Crore via a share swap, achieving full ownership.
- Value
- ₹176.0 Cr
Amber Enterprises India Acquisition Worth ₹13.12 Cr
Amber's subsidiary IL JIN Electronics will acquire the remaining 1.50% stake in Ascent Circuits, making it a wholly-owned subsidiary via a ₹13.12 Crore share swap.
- Value
- ₹13.12 Cr
- Execution
- 10 Business Days from the Execution Date
Amber Enterprises India Management Change
Amber Enterprises' subsidiary, IL JIN Electronics, appointed Mr. Satendra Singh as CEO and Whole-Time Director, while Mr. Sanjay Kumar Arora ceased his directorship.
Amber Enterprises India Merger & Restructuring Worth ₹0.01 Cr
Amber Enterprises India incorporated Amber Digital Technologies Pvt Ltd, a 100% subsidiary, to begin mobile phone manufacturing. Funded with ₹0.01 Crore subscription money in India.
- Value
- ₹0.01 Cr
Amber Enterprises India Capacity Expansion: ₹0.01 Cr Investment
Amber Enterprises incorporated subsidiary Amber Digital Technologies to enter mobile phone manufacturing. Initial subscription of ₹0.01 Crore was infused for this new electronics and telecom venture.
- Value
- ₹0.01 Cr
Amber Enterprises India Insurance Claim: ₹38.28 Cr
Amber Enterprises reported an estimated ₹38.28 crore loss from a fire at its subsidiary, IL JIN. The insurer has already released a ₹10 crore interim payment.
- Value
- ₹38.28 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.